Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:03 PM
Ignite Modification Date:
2025-12-24 @ 10:03 PM
NCT ID:
NCT00022035
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of acute lymphoblastic leukemia
* In first remission after completion of induction chemotherapy
* Currently on active treatment OR
* Completed treatment within the past 6 months
PATIENT CHARACTERISTICS:
Age:
* 1 to 20 at time of diagnosis
Performance status:
* Not specified
Life expectancy:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
Pulmonary:
* No acute respiratory distress
Other:
* No history of Guillain-Barre syndrome
* No history of hypersensitivity to chicken eggs, egg products, or components of influenza virus vaccine, including thimerosal
* No febrile illness with fever over 100.4 degrees F
* Not pregnant or nursing
* Fertile patients must use effective contraception
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* See Disease Characteristics
Endocrine therapy:
* Not specified
Radiotherapy:
* Not specified
Surgery:
* Not specified
Other:
* At least 7 days since prior antibiotic or antiviral therapy except prophylactic antibiotics
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
20 Years
Study:
NCT00022035
Study Brief:
Protocol Section:
NCT00022035